The Venture Codex Logo

The Venture Codex

LYZZ Capital

Room A 2203, Tower A SOHO Fuxing Plaza 388 Ma Dang Road, Shanghai, Huang Pu District, 200025, China

Overview

Venture capital firm specializing in seed and early-stage investments.

Founded

2014

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

China
United States

Sector focus

—

Investment portfolio

8rounds
NAMEDATESIZE
Onchilles Pharma
Nov 2025Participated
$25 MSeries A
Mojia Bioscience
Jun 2022Participated
$80 MSeries B
OncoMyx Therapeutics
Dec 2021Participated
$50 MSeries B
Onchilles Pharma
Jun 2021Led
$7 MSeries A
Neurelis
Mar 2021Participated
$114 MSeries D
Jumpcode Genomics
Feb 2021Participated
$21 MSeries B
Qpex Biopharma
Oct 2018Participated
$33 MSeries A
Alpha Biopharma
Jun 2018Participated
$37 MSeries A
Onchilles Pharma
Nov 2025Participated
$25 MSeries A
Mojia Bioscience
Jun 2022Participated
$80 MSeries B
OncoMyx Therapeutics
Dec 2021Participated
$50 MSeries B
Onchilles Pharma
Jun 2021Led
$7 MSeries A
Neurelis
Mar 2021Participated
$114 MSeries D
Jumpcode Genomics
Feb 2021Participated
$21 MSeries B
Qpex Biopharma
Oct 2018Participated
$33 MSeries A
Alpha Biopharma
Jun 2018Participated
$37 MSeries A
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

LYZZ Capital: 8 funding rounds are recorded in the selected participation categories.All available history.
LYZZ Capital: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A13
Series B03
Series C+01

Monthly Deal Activity

LYZZ Capital: 8 deals are recorded across 101 months.All available history.
LYZZ Capital: 8 deals are recorded across 101 months. All available history
MonthDeals
Jun '181
Jul '180
Aug '180
Sep '180
Oct '181
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '211
Mar '211
Apr '210
May '210
Jun '211
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '211
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '251
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

LYZZ Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

LYZZ Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Food & Agriculture1

Deal Size Distribution

LYZZ Capital: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

LYZZ Capital: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M1
$25M-$50M3
$50M-$100M2
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

LYZZ Capital: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

LYZZ Capital: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
China2
LYZZ Capital: 20 co-investors are shown, with Adams Street Partners sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

LYZZ Capital: 20 co-investors are shown, with Adams Street Partners sharing 1 recorded deals. All available history
Co-investorShared deals
Adams Street Partners1
Arboretum Ventures1
Asia Green Fund1
B Capital Group1
Baird Capital1
Biomedical Advanced Research and Development Authority1
Bits x Bites1
Boehringer Ingelheim1
City Hill Ventures1
Cormorant Asset Management1
Decheng Capital1
Delos Capital1
Hatteras Venture Partners1
HBM Healthcare Investments1
InVivium Capital1
Kennedy Lewis Investment Management1
Korea Investment Partners1
Lincoln Park Capital1
Lumira Ventures1
Madison Partners1

Investment Strategy

LYZZ Capital: Led accounts for 13% and participating for 88% of round participation.All available history.
LYZZ Capital: Led accounts for 13% and participating for 88% of round participation. All available history
CategoryDeals (count)Share (%)
Led113%
Participating788%
LYZZ Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
LYZZ Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Kevin Li

Founding Managing Partner

Peter Haberz

Principal